Your startup may be doing great, but Greece is a small market. At some point, you will want to consider expansion to the United States. Meet with lawyers
Your startup may be doing great, but Greece is a small market. At some point, you will want to consider expansion to the United States. Meet with lawyers from top-tier US based law firm Foley & Lardner who will discuss the process of setting up operations in the US, and guide you through some of the relevant considerations.
Mark your calendars and save the date to attend our first event on the 𝟯𝟭𝘀𝘁 𝗼𝗳 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 at Biomedical Research Foundation Academy of Athens.
David W. Kantaros serves as Co-Chair for Artificial Intelligence within our Innovative Technology sector and is a member of the Private Equity & Venture Capital and Transactional & Securities Practices. He represents venture capital and private equity funds as well as publicly and privately held corporations in the emerging technology and life science industries. David has lectured on issues relating to representation of venture capital funds and portfolio companies in private equity financings, representing buyers and sellers in mergers and acquisitions and the structuring of strategic relationships and joint ventures around technology developments. David has been selected for inclusion in the 2005 and 2006 Massachusetts Super Lawyers–Rising Stars® editions for his work in securities and corporate finance. He has also been selected by his peers for inclusion in The Best Lawyers in America© since 2012 in the field of Venture Capital Law.
Kyle Faget is a Boston-based partner and a health care and life sciences lawyer with Foley & Lardner LLP. Kyle is the Co-Chair of the firm’s Health Care and Life Sciences Practice Groups, and she is a core member of the firm’s telemedicine industry team. Kyle advises investors, academic medical centers, physician practices, and consultants on a range of business, legal and regulatory issues affecting the telemedicine industry. She helps companies build and refine corporate compliance programs, including advising clients on regulatory and compliance matters involving the Food, Drug and Cosmetic Act (FDCA), the False Claims Act (FCA), the Anti-Kickback Statute (AKS), the AdvaMed Code and the PhRMA Code. She regularly drafts and negotiates agreements required for the development and commercialization of pharmaceutical and medical device products, including licensing agreements, collaboration agreements, clinical trial agreements, and an array services agreements. Prior to joining the firm, Kyle held in-house positions at pre-commercial and commercial stage companies.
(Thursday) 5:00 pm - 9:00 pm